The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

Completed · Not applicable

Conditions studied: Head Trauma

In brief

Nutrition interventions may present a safe and relatively risk free intervention for protection against subconcussive impacts. Docosahexaenoic acid (DHA, 22:6n-3) is the principal Omega 3 polyunsaturated fatty acid in the brain, playing an integral role in the brain's development and structural integrity. The goal of this study is to determine if supplementation with DHA attenuates blood biomarkers of repetitive head trauma linked to sub-concussive impacts sustained in rugby participation.

Key facts

Study ID

NCT03582267

Run by

Texas Christian University

People needed

50

Starts

2017-08-01

Expected to finish

2019-08-01

Last updated by the study team

2019-09-13

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Canadian national rugby athletes on 7s and 15s teams

You may not qualify if…

• None

Where it is running

• Texas Christian Universti — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.